Essential n-3 fatty acids in cardiac insufficiency and heart...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/23 (2006.01) A61K 31/355 (2006.01) A61P 9/00 (2006.01) A61P 9/04 (2006.01) A61P 9/10 (2006.01) A61K 31/202 (2006.01)

Patent

CA 2433762

The present invention concerns a method of therapeutic prevention and treatment of a heart disease chosen from cardiac insufficiency and heart failure including the administration of an essential fatty acid containing a mixture of eicosapentaenoic acid ethyl ester (EPA) and docosahexaenoic acid ethyl ester (DHA), either alone or in combination with another therapeutic agent.

L'invention concerne une méthode de prévention thérapeutique et de traitement d'une maladie cardiaque, choisie entre l'insuffisance cardiaque et l'arrêt cardiaque. Cette méthode consiste à administrer un acide gras essentiel contenant un mélange d'ester éthylique d'acide eicosapentanoïque (EPA) et d'ester éthylique d'acide docosahexanoïque (DHA), seul ou associé à un autre agent thérapeutique.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Essential n-3 fatty acids in cardiac insufficiency and heart... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Essential n-3 fatty acids in cardiac insufficiency and heart..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Essential n-3 fatty acids in cardiac insufficiency and heart... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1975456

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.